Literature DB >> 7841814

Frontal lobe dysfunction in secondary depression.

H S Mayberg1.   

Abstract

Depression is common in patients with neurological disease, particularly with diseases involving the basal ganglia. Although the mechanisms of mood disorders in these patients are poorly understood, selective neural pathways affected directly and indirectly by basal ganglia injury provide a strategy for examining these patients with functional imaging techniques. Studies of regional cerebral glucose metabolism by use of positron-emission tomography are reviewed. These studies demonstrate bilateral hypometabolism of orbital-inferior prefrontal cortex and anterior temporal cortex in depressed subjects, independent of disease etiology. This pattern is similar to that seen in patients with primary unipolar depression. These findings suggest that disruption of paralimbic pathways linking frontal cortex, temporal cortex, and striatum may contribute to both primary depression and depression associated with basal ganglia disease. The findings support the evolving concept of a neuroanatomical locus for mood regulation.

Entities:  

Mesh:

Year:  1994        PMID: 7841814     DOI: 10.1176/jnp.6.4.428

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  40 in total

1.  Internally vs. externally triggered movements in patients with major depression.

Authors:  Felix Hoffstaedter; Jan Sarlon; Christian Grefkes; Simon B Eickhoff
Journal:  Behav Brain Res       Date:  2011-11-28       Impact factor: 3.332

2.  Apathy and depression: separate factors in Parkinson's disease.

Authors:  Lindsey Kirsch-Darrow; Michael Marsiske; Michael S Okun; Russell Bauer; Dawn Bowers
Journal:  J Int Neuropsychol Soc       Date:  2011-11       Impact factor: 2.892

3.  Brain mechanisms of stress and depression in coronary artery disease.

Authors:  J Douglas Bremner; Carolina Campanella; Zehra Khan; Negar Fani; Nicole Kasher; Sarah Evans; Collin Reiff; Sanskriti Mishra; Stacy Ladd; Jonathon A Nye; Paolo Raggi; Viola Vaccarino
Journal:  J Psychiatr Res       Date:  2018-11-22       Impact factor: 4.791

4.  Brain-derived neurotrophic factor Val⁶⁶Met polymorphism affects resting regional cerebral blood flow and functional connectivity differentially in women versus men.

Authors:  Shau-Ming Wei; Daniel P Eisenberg; Philip D Kohn; Jonathan S Kippenhan; Bhaskar S Kolachana; Daniel R Weinberger; Karen F Berman
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

Review 5.  Targeted electrode-based modulation of neural circuits for depression.

Authors:  Helen S Mayberg
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

Review 6.  Rethinking the thinking cap: ethics of neural enhancement using noninvasive brain stimulation.

Authors:  Roy Hamilton; Samuel Messing; Anjan Chatterjee
Journal:  Neurology       Date:  2011-01-11       Impact factor: 9.910

7.  An extract of Synedrella nodiflora (L) Gaertn exhibits antidepressant properties through monoaminergic mechanisms.

Authors:  Patrick Amoateng; Kennedy Kwami Edem Kukuia; Jeffrey Amoako Mensah; Dorcas Osei-Safo; Samuel Adjei; Audrey Akyea Eklemet; Emmanuel Atsu Vinyo; Thomas K Karikari
Journal:  Metab Brain Dis       Date:  2018-05-12       Impact factor: 3.584

8.  Sleep deprivation increases dorsal nexus connectivity to the dorsolateral prefrontal cortex in humans.

Authors:  Oliver G Bosch; Julia S Rihm; Milan Scheidegger; Hans-Peter Landolt; Philipp Stämpfli; Janis Brakowski; Fabrizio Esposito; Björn Rasch; Erich Seifritz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 9.  Comparison of prefrontal cell pathology between depression and alcohol dependence.

Authors:  José J Miguel-Hidalgo; Grazyna Rajkowska
Journal:  J Psychiatr Res       Date:  2003 Sep-Oct       Impact factor: 4.791

Review 10.  Current insights into the pathophysiology of irritable bowel syndrome.

Authors:  Ines Schwetz; Sylvie Bradesi; Emeran A Mayer
Journal:  Curr Gastroenterol Rep       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.